Medical Condition News

RSS

Pulmonary fibrosis associated with short and long sleep duration

Scientists have discovered that people who regularly sleep for more than 11 hours or less than 4 hours are 2-3 times more likely to have the incurable disease, pulmonary fibrosis, compared to those that sleep for 7 hours in a day. They attribute this association to the body clock.

30 Dec 2019

Scientists discover potential drug compounds that target common type of liver cancer

Scientists from the Cancer Science Institute of Singapore at the National University of Singapore, and the Agency for Science, Technology and Research (A*STAR)'s Genome Institute of Singapore have discovered four potential drug compounds that target hepatocellular carcinoma, the most common type of liver cancer.

30 Dec 2019

Study uncovers key protein that supports the growth of many colorectal cancers

Researchers at the University of Toronto have identified a key protein that supports the growth of many colorectal cancers.

28 Dec 2019

Study shows abnormal cardiovascular response to nitroglycerin in migraine patients

A clinical investigation recently published in the journal Cephalalgia, the official journal of the International Headache Society, suggests that migraine patients may exhibit a systemic pathophysiological alteration.

28 Dec 2019

Proton therapy has similar cure rates, fewer serious side effects compared with traditional radiation

Cancer patients who receive high-tech proton therapy experience similar cure rates and fewer serious side effects compared with those who undergo traditional X-ray radiation therapy, according to a study led by Washington University School of Medicine in St. Louis and the Perelman School of Medicine at the University of Pennsylvania.

28 Dec 2019

Recommended amounts of physical activity associated with reduced risk for seven cancers

A pooled analysis of nine prospective studies involving more than 750,000 adults finds that recommended amounts of leisure-time physical activity were linked to a lower risk for seven cancers, with several cancer types having a 'dose/response' relationship.

27 Dec 2019

A new kind of testing for patients with Parkinson's disease

Parkinson's disease is a neurodegenerative disorder that manifests through symptoms such as tremor, slow movements, limb rigidity and gait and balance problems.

26 Dec 2019

New discovery has implications for better restoration of sight in AMD patients

Macular degeneration causes blindness in millions of people in the Western world. It is the most common cause of severe vision loss in the Western world among those aged 50 and over, and its prevalence increases with age.

26 Dec 2019

Yale Cancer Center launches CEHE to ensure health equity and improve patient outcomes

Yale Cancer Center announces the launch of the Center for Community Engagement and Health Equity.

26 Dec 2019

Proton therapy reduces the relative risk of side effects for cancer patients

Proton therapy leads to significantly lower risk of side effects severe enough to lead to unplanned hospitalizations for cancer patients when compared with traditional radiation, while cure rates between the two groups are almost identical.

26 Dec 2019

High BMI may improve the chance of survival in certain cancers

Above average or high BMI - often linked to cancers, diabetes, cardiovascular and other diseases - may in some cases improve the chance of survival among certain cancers, new research from Flinders University indicates.

26 Dec 2019

Lab-grown brain organoids may hold the answers to personalized treatments for glioblastomas

Lab-grown brain organoids developed from a patient's own glioblastoma, the most aggressive and common form of brain cancer, may hold the answers on how to best treat it.

26 Dec 2019

Transcendental Meditation technique helps prevent left ventricular hypertrophy

A randomized controlled study recently published in Ethnicity & Disease in their Autumn 2019 Hypertension issue found that the Transcendental Meditation technique helps to prevent abnormal enlargement of the heart compared to health education controls.

26 Dec 2019

Study uncovers novel targetable axis in mesothelioma patients

A collaborative study of researchers from Thomas Jefferson University, Sbarro Institute for Cancer Research and Molecular Medicine of Temple University, University of Siena, and from the Spanish Center for the Applied Medical Research of the University of Navarra have discovered a novel targetable axis in mesothelioma patients.

26 Dec 2019

Many stomach cancer patients under 60 have a 'genetically and clinically distinct' disease

Many people under 60 who develop stomach cancer have a "genetically and clinically distinct" disease, new Mayo Clinic research has discovered.

26 Dec 2019

Study measures brain injury from boxing, MMA in younger and older fighters

For boxers and mixed martial arts (MMA) fighters, is there a safe level of exposure to head trauma? A new study shows different effects in the brain for younger, current fighters compared to older, retired fighters.

23 Dec 2019

Synthetic mRNA nanoparticles restore tumor suppressor gene, make cancer cells susceptible to drugs

In preclinical experiments, investigators restored p53 using synthetic mRNA nanoparticles, making lung and liver cancer cells susceptible to available cancer drugs.

23 Dec 2019

New 'fishing' technique to detect thousands of proteins

A new study published today in the journal Nature Cell Biology reports the use of a novel fishing method, under microscopy, to pick up thousands of proteins that are involved in supervising how the cell skeleton is assembled.

23 Dec 2019

Research findings may one day help keep ALS at bay

A new study published in the journal Nature Medicine on December 23, 2019, shows how to silence a defective gene responsible for the degeneration of the motor neurons in Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS), in adult mice. This could help prevent disease progression if the condition is already symptomatic, and even suppress the illness if it has not yet started.

23 Dec 2019

Immunosupressant combination therapy for glioblastoma shows promise

Researchers from the University of Texas have found an immunosuppressing target for the treatment of glioblastoma. In mice studies the team has identified CD73 macrophages which could be used to treat the cancers. The team also performed studies on human tumours to arrive at their conclusions. The study was published in the latest issue of the journal Nature Medicine this week.

23 Dec 2019

Medical Condition News

Pulmonary fibrosis associated with short and long sleep duration

Scientists discover potential drug compounds that target common type of liver cancer

Study uncovers key protein that supports the growth of many colorectal cancers

Study shows abnormal cardiovascular response to nitroglycerin in migraine patients

Proton therapy has similar cure rates, fewer serious side effects compared with traditional radiation

Recommended amounts of physical activity associated with reduced risk for seven cancers

A new kind of testing for patients with Parkinson's disease

New discovery has implications for better restoration of sight in AMD patients

Yale Cancer Center launches CEHE to ensure health equity and improve patient outcomes

Proton therapy reduces the relative risk of side effects for cancer patients

High BMI may improve the chance of survival in certain cancers

Lab-grown brain organoids may hold the answers to personalized treatments for glioblastomas

Transcendental Meditation technique helps prevent left ventricular hypertrophy

Study uncovers novel targetable axis in mesothelioma patients

Many stomach cancer patients under 60 have a 'genetically and clinically distinct' disease

Study measures brain injury from boxing, MMA in younger and older fighters

Synthetic mRNA nanoparticles restore tumor suppressor gene, make cancer cells susceptible to drugs

New 'fishing' technique to detect thousands of proteins

Research findings may one day help keep ALS at bay

Immunosupressant combination therapy for glioblastoma shows promise

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News